Company intelligence / Profile preview

PrimeSyn Lab

Princeton, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

PrimeSyn Lab Inc. was a contract research organization (CRO) specializing in custom DNA and peptide synthesis, as well as protein analysis and characterization. Founded in 2002 and based in Princeton, New Jersey, the company provided high-quality synthetic oligonucleotides, modified peptides, and isotopically labeled oligomers to the biotechnology and pharmaceutical industries. Their service portfolio included assay design and advanced analytical techniques such as HPLC, circular dichroism, and LC-MS/MS to support drug discovery and regulatory compliance. Led by CEO Dr. Surendra Chaturvedi, PrimeSyn Lab served as a technical partner for academic and industrial researchers before ceasing operations.

Modalities: PeptidesOligonucleotides
Industry: Drug Discovery Services

Partnerships

Premier Biosoft International

Beyond the preview

Go deeper on PrimeSyn Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrimeSyn Lab.

Explore the full profile